Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker

ABSTRACT Background Non‐small cell lung carcinoma (NSCLC) is a leading cause of cancer‐related mortality, with recurrence risks posing significant challenges in early‐stage disease management. While epidermal growth factor receptor (EGFR) mutations are common, the role of concurrent genetic alterati...

Descripción completa

Detalles Bibliográficos

Autores principales:	Meejeong Kim, Gyeong Sin Park, Kyo Young Lee, Seok Whan Moon, Yeoun Eun Sung
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2025-04-01
Colección:	Thoracic Cancer
Materias:	early‐stage lung cancer EGFR amplification EGFR mutation non‐small cell lung cancer (NSCLC) TP53 mutation
Acceso en línea:	https://doi.org/10.1111/1759-7714.70058
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!